Staber et al. [11] demonstrated that recurrent AML is commonly associated with mRNA expression changes in a set of 58 genes, such as the angiogenic molecules’ fibroblast growth factor receptor-1 and thrombospondin-2. This evidence concerns the gene THBS2 and acute myeloid leukemia.